Qube Research & Technologies (QRT)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39M Sell
689,721
-746,918
-52% -$43.5M 0.06% 533
2025
Q4
$85.4M Buy
1,436,639
+1,176,410
+452% +$64M 0.12% 299
2025
Q3
$14.1M Sell
260,229
-380,164
-59% -$21.7M 0.02% 1102
2025
Q2
$35.2M Buy
+640,393
New +$37.7M 0.05% 600
2025
Q1
Sell
-6,576
Closed -$432K 3511
2024
Q4
$432K Buy
+6,576
New +$440K ﹤0.01% 2544
2024
Q3
Sell
-14
Closed -$1.15K 3348
2024
Q2
$1.15K Sell
14
-14,835
-100% -$1.24M ﹤0.01% 3246
2024
Q1
$1.3M Buy
14,849
+4,319
+41% +$387K ﹤0.01% 1992
2023
Q4
$1.02M Sell
10,530
-71,145
-87% -$6.29M ﹤0.01% 1921
2023
Q3
$7.23M Sell
81,675
-407,530
-83% -$36.3M 0.02% 771
2023
Q2
$42.4M Buy
489,205
+12,454
+3% +$1.17M 0.16% 186
2023
Q1
$46.4M Buy
476,751
+211,481
+80% +$21.9M 0.27% 98
2022
Q4
$27.5M Buy
265,270
+169,933
+178% +$16M 0.17% 185
2022
Q3
$8.08M Buy
+95,337
New +$8.49M 0.05% 467
2022
Q2
Sell
-268,780
Closed -$20.7M 2520
2022
Q1
$20.7M Buy
+268,780
New +$22.5M 0.19% 146
2021
Q4
Sell
-24,205
Closed -$1.87M 2537
2021
Q3
$1.87M Buy
24,205
+10,252
+73% +$809K 0.02% 699
2021
Q2
$1.16M Buy
13,953
+3,197
+30% +$253K 0.01% 880
2021
Q1
$812K Buy
+10,756
New +$879K 0.01% 934
2020
Q4
Sell
-52,118
Closed -$3.96M 1821
2020
Q3
$3.96M Buy
52,118
+45,906
+739% +$4.64M 0.06% 433
2020
Q2
$766K Buy
+6,212
New +$617K 0.01% 956
2019
Q3
Sell
-6,387
Closed -$547K 262
2019
Q2
$547K Buy
6,387
+2,334
+58% +$200K 0.13% 169
2019
Q1
$360K Buy
+4,053
New +$376K 0.05% 366
2018
Q4
Sell
-2,704
Closed -$262K 364
2018
Q3
$262K Buy
+2,704
New +$270K 0.03% 395

Other funds holding BMRN